BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25768874)

  • 41. Building capacity for cervical cancer screening in outpatient HIV clinics in the Nyanza province of western Kenya.
    Huchko MJ; Bukusi EA; Cohen CR
    Int J Gynaecol Obstet; 2011 Aug; 114(2):106-10. PubMed ID: 21620403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Implementation of cervical cancer screening using visual inspection with acetic acid in rural Mozambique: successes and challenges using HIV care and treatment programme investments in Zambézia Province.
    Moon TD; Silva-Matos C; Cordoso A; Baptista AJ; Sidat M; Vermund SH
    J Int AIDS Soc; 2012 Jun; 15(2):17406. PubMed ID: 22713260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implementation and feasibility of an adapted two-stage visual inspection with acetic acid/cryotherapy-based cervical cancer screening programme for HIV-infected women in Addis Ababa, Ethiopia.
    Price JT; Asgary R
    Eur J Cancer Care (Engl); 2016 May; 25(3):526-7. PubMed ID: 27121898
    [No Abstract]   [Full Text] [Related]  

  • 44. Increased Cervical Human Immunodeficiency Virus (HIV) RNA Shedding Among HIV-Infected Women Randomized to Loop Electrosurgical Excision Procedure Compared to Cryotherapy for Cervical Intraepithelial Neoplasia 2/3.
    Greene SA; McGrath CJ; Lehman DA; Marson KG; Trinh TT; Yatich N; Nyongesa-Malava E; Kiptinness C; Richardson BA; John-Stewart GC; De Vuyst H; Sakr SR; Mugo NR; Chung MH
    Clin Infect Dis; 2018 May; 66(11):1778-1784. PubMed ID: 29272368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention of cervical cancer in low-resource settings.
    Suba EJ; Geisinger KR; Zarka MA; Raab SS
    JAMA; 2006 Mar; 295(11):1248-9; author reply 1249. PubMed ID: 16537731
    [No Abstract]   [Full Text] [Related]  

  • 46. Prevalence of Cervical Dysplasia in HIV-Positive and HIV-Negative Women at the Sihanouk Hospital Center of HOPE, Phnom Penh , Cambodia.
    Thay S; Peprah SA; Hur C; Tramontano AC; Maling E; Goldstein AT; Hong C
    Asian Pac J Cancer Prev; 2019 Feb; 20(2):653-659. PubMed ID: 30816687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Uptake and safety of community-based "screen-and-treat" with thermal ablation preventive therapy for cervical cancer prevention in rural Lilongwe, Malawi.
    Chinula L; Topazian HM; Mapanje C; Varela A; Chapola J; Limarzi L; Stanley C; Hosseinipour M; Gopal S; Tang JH
    Int J Cancer; 2021 Jul; 149(2):371-377. PubMed ID: 33687746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cervical dysplasia in women with HIV.
    Goodman L; Croke V; Rodman A; Alexander MK
    Nurse Pract; 1999 Aug; 24(8):79-80, 82, 84-5. PubMed ID: 10479112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review.
    Okeah BO; Ridyard CH
    Appl Health Econ Health Policy; 2020 Oct; 18(5):641-654. PubMed ID: 32468410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recurrence of cervical intraepithelial lesions after thermo-coagulation in HIV-positive and HIV-negative Nigerian women.
    Oga EA; Brown JP; Brown C; Dareng E; Adekanmbi V; Odutola M; Olaniyan O; Offiong R; Obende K; Adewole AS; Peter A; Dakum P; Adebamowo C
    BMC Womens Health; 2016 May; 16():25. PubMed ID: 27169666
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ablative Therapies for Cervical Intraepithelial Neoplasia in Low-Resource Settings: Findings and Key Questions.
    Cremer ML; Conzuelo-Rodriguez G; Cherniak W; Randall T
    J Glob Oncol; 2018 Oct; 4():1-10. PubMed ID: 30372399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A clinical decision analysis of cryotherapy compared with expectant management for cervical dysplasia.
    Hamm RM; Loemker V; Reilly KL; Johnson G; Dubois P; Staveley-O'Carroll K; Brand J; Owens T; Smith K
    J Fam Pract; 1998 Sep; 47(3):193-201. PubMed ID: 9752371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors influencing cervical cancer screening in women infected with HIV: a review of the literature.
    Chapman Lambert CL
    J Assoc Nurses AIDS Care; 2013; 24(3):189-97. PubMed ID: 22999769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successes and challenges of establishing a cervical cancer screening and treatment program in western Kenya.
    Khozaim K; Orang'o E; Christoffersen-Deb A; Itsura P; Oguda J; Muliro H; Ndiema J; Mwangi G; Strother M; Cu-Uvin S; Rosen B; Washington S
    Int J Gynaecol Obstet; 2014 Jan; 124(1):12-8. PubMed ID: 24140218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
    Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
    J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of social services interventions in developing countries: a review of the evidence of impact on clinical outcomes in people living with HIV.
    Bateganya MH; Dong M; Oguntomilade J; Suraratdecha C
    J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(0 3):S357-67. PubMed ID: 25768875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosing cervical dysplasia using visual inspection of the cervix with acetic acid in a woman in rural Haiti.
    Roger E; Nwosu O
    Int J Environ Res Public Health; 2014 Nov; 11(12):12304-11. PubMed ID: 25464128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estimating the costs of cervical cancer screening in high-burden Sub-Saharan African countries.
    Mvundura M; Tsu V
    Int J Gynaecol Obstet; 2014 Aug; 126(2):151-5. PubMed ID: 24792401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. World Health Organization Guidelines: Use of cryotherapy for cervical intraepithelial neoplasia.
    Santesso N; Schünemann H; Blumenthal P; De Vuyst H; Gage J; Garcia F; Jeronimo J; Lu R; Luciani S; Quek SC; Awad T; Broutet N;
    Int J Gynaecol Obstet; 2012 Aug; 118(2):97-102. PubMed ID: 22727415
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia.
    Korn AK; Muzingwani L; O'Bryan G; Ensminger A; Boylan AD; Kafidi EL; Kashali M; Ashipala L; Nitschke AM; Dziuban EJ; Forster N; Eckert LO; O'Malley G
    PLoS One; 2022; 17(2):e0263920. PubMed ID: 35171941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.